ATXS
Price
$7.30
Change
+$0.15 (+2.10%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
411.97M
46 days until earnings call
OLMA
Price
$9.51
Change
+$1.32 (+16.12%)
Updated
Sep 26 closing price
Capitalization
652.71M
45 days until earnings call
Interact to see
Advertisement

ATXS vs OLMA

Header iconATXS vs OLMA Comparison
Open Charts ATXS vs OLMABanner chart's image
Astria Therapeutics
Price$7.30
Change+$0.15 (+2.10%)
Volume$3.97K
Capitalization411.97M
Olema Pharmaceuticals
Price$9.51
Change+$1.32 (+16.12%)
Volume$1.41M
Capitalization652.71M
ATXS vs OLMA Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. OLMA commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and OLMA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ATXS: $7.30 vs. OLMA: $9.51)
Brand notoriety: ATXS and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 90% vs. OLMA: 164%
Market capitalization -- ATXS: $411.97M vs. OLMA: $652.71M
ATXS [@Biotechnology] is valued at $411.97M. OLMA’s [@Biotechnology] market capitalization is $652.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATXS and OLMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while OLMA’s TA Score has 5 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 6 bearish.
  • OLMA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OLMA is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а +3.55% price change this week, while OLMA (@Biotechnology) price change was +16.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

OLMA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OLMA($653M) has a higher market cap than ATXS($412M). OLMA YTD gains are higher at: 63.122 vs. ATXS (-18.345). ATXS has higher annual earnings (EBITDA): -131.42M vs. OLMA (-156.66M). OLMA has more cash in the bank: 362M vs. ATXS (259M). OLMA (4.76M) and ATXS (4.77M) have identical debt. ATXS (0) and OLMA (0) have equivalent revenues.
ATXSOLMAATXS / OLMA
Capitalization412M653M63%
EBITDA-131.42M-156.66M84%
Gain YTD-18.34563.122-29%
P/E RatioN/AN/A-
Revenue00-
Total Cash259M362M72%
Total Debt4.77M4.76M100%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSOLMA
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVSVX19.890.17
+0.86%
Third Avenue Small Cap Value Investor
AGTIX171.400.50
+0.29%
AB Sustainable Global Thematic I
FBCVX24.53N/A
N/A
Fidelity Blue Chip Value
OPTIX113.47N/A
N/A
Invesco Discovery Large Cap R6
LIONX10.09N/A
N/A
Issachar N

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+2.10%
CRNX - ATXS
53%
Loosely correlated
+27.92%
DNLI - ATXS
51%
Loosely correlated
+3.87%
XENE - ATXS
51%
Loosely correlated
+4.00%
VRDN - ATXS
51%
Loosely correlated
+5.77%
NRIX - ATXS
50%
Loosely correlated
+7.20%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with IDYA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
+16.12%
IDYA - OLMA
46%
Loosely correlated
+4.44%
ATXS - OLMA
44%
Loosely correlated
+2.10%
ARWR - OLMA
44%
Loosely correlated
+3.60%
EYPT - OLMA
44%
Loosely correlated
+5.38%
CRNX - OLMA
43%
Loosely correlated
+27.92%
More